Verve Therapeutics Statistics
Total Valuation
STO:MAGLE has a market cap or net worth of SEK 422.63 million. The enterprise value is 763.11 million.
Market Cap | 422.63M |
Enterprise Value | 763.11M |
Important Dates
The last earnings date was Friday, August 1, 2025.
Earnings Date | Aug 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
STO:MAGLE has 20.52 million shares outstanding.
Current Share Class | 20.52M |
Shares Outstanding | 20.52M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 8.85% |
Owned by Institutions (%) | 0.01% |
Float | 10.57M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 24.24 |
PS Ratio | 1.46 |
PB Ratio | 0.80 |
P/TBV Ratio | 1.79 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.20, with an EV/FCF ratio of -27.10.
EV / Earnings | -37.86 |
EV / Sales | 2.63 |
EV / EBITDA | 17.20 |
EV / EBIT | n/a |
EV / FCF | -27.10 |
Financial Position
The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.65.
Current Ratio | 0.57 |
Quick Ratio | 0.24 |
Debt / Equity | 0.65 |
Debt / EBITDA | 7.72 |
Debt / FCF | -12.17 |
Interest Coverage | -1.00 |
Financial Efficiency
Return on equity (ROE) is -5.85% and return on invested capital (ROIC) is -1.83%.
Return on Equity (ROE) | -5.85% |
Return on Assets (ROA) | -1.51% |
Return on Invested Capital (ROIC) | -1.83% |
Return on Capital Employed (ROCE) | -2.58% |
Revenue Per Employee | 2.00M |
Profits Per Employee | -139,000 |
Employee Count | 147 |
Asset Turnover | 0.43 |
Inventory Turnover | 0.28 |
Taxes
Income Tax | -57,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.76% in the last 52 weeks. The beta is 0.47, so STO:MAGLE's price volatility has been lower than the market average.
Beta (5Y) | 0.47 |
52-Week Price Change | -50.76% |
50-Day Moving Average | 26.29 |
200-Day Moving Average | 30.82 |
Relative Strength Index (RSI) | 21.27 |
Average Volume (20 Days) | 1,916 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:MAGLE had revenue of SEK 290.43 million and -20.16 million in losses.
Revenue | 290.43M |
Gross Profit | 265.00M |
Operating Income | -16.20M |
Pretax Income | -20.21M |
Net Income | -20.16M |
EBITDA | 36.15M |
EBIT | -16.20M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 2.15 million in cash and 342.64 million in debt, giving a net cash position of -340.48 million or -16.60 per share.
Cash & Cash Equivalents | 2.15M |
Total Debt | 342.64M |
Net Cash | -340.48M |
Net Cash Per Share | -16.60 |
Equity (Book Value) | 529.23M |
Book Value Per Share | n/a |
Working Capital | -174.71M |
Cash Flow
In the last 12 months, operating cash flow was -23.39 million and capital expenditures -4.78 million, giving a free cash flow of -28.16 million.
Operating Cash Flow | -23.39M |
Capital Expenditures | -4.78M |
Free Cash Flow | -28.16M |
FCF Per Share | -1.37 |
Margins
Gross margin is 91.24%, with operating and profit margins of -5.58% and -6.94%.
Gross Margin | 91.24% |
Operating Margin | -5.58% |
Pretax Margin | -6.96% |
Profit Margin | -6.94% |
EBITDA Margin | 12.45% |
EBIT Margin | -5.58% |
FCF Margin | n/a |
Dividends & Yields
STO:MAGLE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -4.77% |
FCF Yield | -6.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |